Genes
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
85,013 comparisons from ClinicalTrials.gov. Counted 2026-11-10.
Most participants first33,758 with no events in either group come last81 to 100 of 85,013
| Comparison | With the outcome | Risk difference, 95% interval | Participants | Trial |
|---|---|---|---|---|
| 5ARI Users vs Non 5ARI Users: Suicide (Based on Administrative Data Elements From Ontario Registrar General Death Database, National Ambulatory Care Reporting System, Hospital Discharge Abstracts, and Ontario Regional Mental Health Database) | 38 of 93,197 36 of 93,197 | 0.0 points -0.0 to 0.0 | 186,394 | NCT02876757 5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression |
| 5ARI Users vs Non 5ARI Users: deaths from any cause | 160 of 93,197 139 of 93,197 | 0.0 points -0.0 to 0.1 | 186,394 | NCT02876757 5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression |
| 5ARI Users vs Non 5ARI Users: Suicide Attempt (Based on Administrative Data Elements From National Ambulatory Care Reporting System, and Ontario Regional Mental Health Database) | 169 of 93,197 130 of 93,197 | 0.0 points 0.0 to 0.1 | 186,394 | NCT02876757 5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression |
| 5ARI Users vs Non 5ARI Users: Depression (Based on Administrative Data Elements From Hospital Discharge Abstract Database, and Ontario Regional Mental Health Database and Ontario Health Insurance Plan) | 1,750 of 89,844 1,231 of 89,844 | 0.6 points 0.5 to 0.7 | 179,688 | NCT02876757 5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression |
| Cases vs Controls: Number of Participants Aged 45-64 With Diagnosis of Venous Thromboembolism After the Start of Follow-up for Each Person | 639 of 33,497 1,858 of 133,987 | 0.5 points 0.4 to 0.7 | 167,484 | NCT04969653 The Incidence of Venous Thromboembolism in Atopic Dermatitis |
| Cases vs Controls: Number of Participants Aged ≥65 With Diagnosis of Venous Thromboembolism After the Start of Follow-up for Each Person | 1,434 of 33,225 4,113 of 132,776 | 1.2 points 1.0 to 1.5 | 166,001 | NCT04969653 The Incidence of Venous Thromboembolism in Atopic Dermatitis |
| Intervention Health Facility Participants vs Control Health Facility Participants: Count of Participants With Maternal Referral, Before or After Delivery | 5,381 of 81,925 4,779 of 79,182 | 0.5 points 0.3 to 0.8 | 161,107 | NCT02148952 BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program |
| Intervention Health Facility Participants vs Control Health Facility Participants: Count of Participants With Newborn Referral | 1,455 of 81,925 1,186 of 79,182 | 0.3 points 0.2 to 0.4 | 161,107 | NCT02148952 BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program |
| Intervention Health Facility Participants vs Control Health Facility Participants: Count of Participants With Cesarean Section | 1,469 of 80,922 1,330 of 78,120 | 0.1 points -0.0 to 0.2 | 159,042 | NCT02148952 BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program |
| Intervention Health Facility Participants vs Control Health Facility Participants: Count of Participants With Stillbirth | 1,513 of 80,061 1,559 of 77,454 | -0.1 points -0.3 to 0.0 | 157,515 | NCT02148952 BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program |
| Intervention Health Facility Participants vs Control Health Facility Participants: Count of Participants With Perinatal Death Within 7 Days | 3,839 of 79,790 3,606 of 77,338 | 0.1 points -0.1 to 0.4 | 157,128 | NCT02148952 BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program |
| Intervention Health Facility Participants vs Control Health Facility Participants: Count of Participants With Hysterectomy Within 7 Days | 19 of 79,705 18 of 77,252 | 0.0 points -0.0 to 0.0 | 156,957 | NCT02148952 BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program |
| Intervention Health Facility Participants vs Control Health Facility Participants: Count of Participants With Blood Transfusion Within 7 Days | 640 of 79,697 625 of 77,254 | -0.0 points -0.1 to 0.1 | 156,951 | NCT02148952 BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program |
| Intervention Health Facility Participants vs Control Health Facility Participants: Count of Mothers Returning to Facility for a Health Problem Within 7 Days | 2,014 of 79,655 2,141 of 77,220 | -0.2 points -0.4 to -0.1 | 156,875 | NCT02148952 BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program |
| Lung Screening vs Control: Lung Cancer Deaths | 1,213 of 77,445 1,230 of 77,456 | -0.0 points -0.1 to 0.1 | 154,901 | NCT01696968 Screening for Lung Cancer in Older Patients (PLCO Screening Trial) |
| Lung Screening vs Control: Lung Cancer Incidence | 1,696 of 77,445 1,620 of 77,456 | 0.1 points -0.0 to 0.2 | 154,901 | NCT01696968 Screening for Lung Cancer in Older Patients (PLCO Screening Trial) |
| Lung Screening vs Control: Deaths From All Causes | 10,827 of 77,445 11,061 of 77,456 | -0.3 points -0.6 to 0.0 | 154,901 | NCT01696968 Screening for Lung Cancer in Older Patients (PLCO Screening Trial) |
| Colorectal Screening vs Control: Colorectal Cancer Incidence | 1,012 of 77,445 1,287 of 77,455 | -0.4 points -0.5 to -0.2 | 154,900 | NCT01696981 Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial) |
| Colorectal Screening vs Control: Deaths From All Causes | 10,835 of 77,445 11,064 of 77,455 | -0.3 points -0.6 to 0.1 | 154,900 | NCT01696981 Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial) |
| Colorectal Screening vs Control: Colorectal Cancer Deaths | 252 of 77,445 341 of 77,455 | -0.1 points -0.2 to -0.1 | 154,900 | NCT01696981 Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial) |
Response
The first 2 of this page's 20 results. GET /api/comparisons/v1?page=5
{
"data": {
"total": 85013,
"results": [
{
"id": "NCT02876757-a3ff0393",
"title": "5ARI Users vs Non 5ARI Users: Suicide (Based on Administrative Data Elements From Ontario Registrar General Death Database, National Ambulatory Care Reporting System, Hospital Discharge Abstracts, and Ontario Regional Mental Health Database)",
"summary": "38 of 93197 against 36 of 93197; risk difference 0.0 points, 95% interval -0.0 to 0.0; NCT02876757, 5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression",
"record": "/library/comparisons/NCT02876757-a3ff0393",
"nct_id": "NCT02876757",
"kind": "outcome",
"participants": 186394,
"risk_difference": {
"value": 0.000021459918237711547,
"lower": -0.00016366130674339946,
"upper": 0.00020733731427011735
},
"group_1": "38 of 93,197",
"group_2": "36 of 93,197",
"difference": "0.0 points",
"interval": "-0.0 to 0.0",
"trial_title": "5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression"
},
{
"id": "NCT02876757-deaths",
"title": "5ARI Users vs Non 5ARI Users: deaths from any cause",
"summary": "160 of 93197 against 139 of 93197; risk difference 0.0 points, 95% interval -0.0 to 0.1; NCT02876757, 5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression",
"record": "/library/comparisons/NCT02876757-deaths",
"nct_id": "NCT02876757",
"kind": "deaths",
"participants": 186394,
"risk_difference": {
"value": 0.000225329141495971,
"lower": -0.00013932970681645535,
"upper": 0.0005919938487861452
},
"group_1": "160 of 93,197",
"group_2": "139 of 93,197",
"difference": "0.0 points",
"interval": "-0.0 to 0.1",
"trial_title": "5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression"
}
],
"no_events": 33758,
"columns": [
{
"key": "title",
"label": "Comparison"
},
{
"key": "group_1",
"label": "With the outcome",
"under": "group_2"
},
{
"key": "difference",
"label": "Risk difference, 95% interval",
"under": "interval"
},
{
"key": "participants",
"label": "Participants"
},
{
"key": "nct_id",
"label": "Trial",
"under": "trial_title"
}
],
"order": "Most participants first",
"kinds": {
"all": 85013,
"outcome": 33568,
"serious-adverse-events": 31897,
"deaths": 19548
}
},
"release": "trial-comparisons-2026-03-23-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "None stated"
}
],
"next": "/api/comparisons/v1?page=6",
"request_id": "xJiGOSw3tNZZ4Zlp"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/comparisons/v1. No key.
GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome
Ask an assistant